Summary In this study we examined both the pH dependence of cathepsin B (cath B) activity and its stability at physiological pH of 7.5 in lung tumours and normal lung tissue by means of fluorogenic assays with Z-Arg-Arg-AMC as specific substrate. Specificity was verified with the cath B blocking inhibitors E-64 and CA-074. With respect to pH dependence of activity, we found a deviation from a normal-shaped pHactivity curve. Besides the typical activity peak at pH 6.0, there were shoulders at pH 4.5-5.5 and at pH 7.0-7.5. This heterogeneity was found in both tumour and normal tissue. To test the stability of cath B at physiological pH of 7.5, homogenates were kept at pH 7.5 for 60 min. Altogether, 82-100% of residual cath B activity was found at pH 5.0-5.5, whereas activity in the range between 5.5 and 7.4 dropped drastically to 26-42%. At pH 7.5, there was still 20-34% residual cath B activity detectable. To test the hypothesis whether the cath B fraction active at pH 7.5 is more abundant in tumour tissues compared with the normal counterparts, we determined this fraction in 91 pairs of lung tumour and normal lung tissue. We found a 2.3-fold increase of median cath B fraction active at pH 7.5 in tumour tissue, although this fraction represented only a small part (about 16%) of the native, acidic (pH 6.0) cath B activity. However, in contrast to native cath B at 6.0, the cath B fraction active at pH 7.5 was related to post-operative probability of survival in curatively operated patients, since activity values higher than 292 (,uEU mg-' protein) were significantly associated with poor prognosis in patients with squamous cell carcinomas (n = 33, P = 0.04). It is concluded that in lung tumour and in normal lung tissue, cath B activity can be divided into at least three fractions with stability optima at different pH values, indicating various forms of cath B. The cath B fraction active at pH 7.5 provides prognostic information in patients with squamous cell carcinoma.
Biochemical studies with purified cathepsin B (cath B; EC 3.4.22.1) revealed a pH optimum at acidic (pH 6.0) and rapid inactivation at alkaline pH (Barrett and Kirschke, 1981; Turk et al, 1994; Kirschke et al, 1995) . In most studies, cath B activity was determined under conditions standardized for the purified enzyme applying a pH of 6.0 (Barrett and Kirschke, 1981) . However, this test does not accurately account for the physiological situation of plasma membrane-associated or -secreted cath B, which are presumably stable and active at physiological pH . Numerous studies have focused on the characterization of cath B from tumours or tumour cells, particularly with respect to its stability and activity at physiological pH (7.3-7.5). These studies described cath B from tumours or tumour cells of breast (Mort et al, 1980; Moin et al, 1992; Buck et al, 1992) , colorectum (Sheahan et al, 1989; Moin et al, 1992) and cervix (Pietras and Roberts, 1981) as well as from sera of tumour-bearing individuals (Pietras et al, 1979; Dufek et al, 1984) being active and stable at pH 7.5. In addition, Buck et al (1992) reported that normal and tumour-derived cath B degraded large extracellular matrix components at neutral pH.
Revised 4 October 1996 Accepted 22 October 1996 Correspondence to: W Ebert, Thoraxklinik Heidelberg-Rohrbach, Amalienstrasse 5, D-69126 Heidelberg, Germany Cath B was shown to appear in differently charged molecular forms (isoforms). Smith et al (1988) described six cath B isoforms with pl between 5.2 and 5.8 in rat pancreas. Ryan et al (1995) found at least three different charged forms with pIs between 4.5 and 5.5 in murine microglia cells. Krepela et al (1995) clearly demonstrated in human lung (tumour and normal) tissue up to 20 differently charged forms of cath B in the pI range 4.33-5.51. Charge differences have also been found for the cath B precursor (Pagano et al, 1989; Werle et al, 1996) . However, it is not known whether differently charged forms of cath B have different trafficking pathways and consequently different subcellular and/or extracellular distribution. It is also not known whether differently charged forms are responsible for the observed stability and activity of cath B at neutral pH, which was reported for tumourassociated cath B in the literature. The first aim of this study was to investigate the stability of cath B activities at different pH upon incubation of tissue homogenates at physiological pH in normal lung tissue as well as in lung tumours.
Cath B activity was found to be poorly correlated with clinical prognostic factors, such as histology or anatomical extent of tumours Ledakis et al, 1996) . However, increased cath B activity Knoch et al, 1994) and protein content (Inoue et al, 1994; Sukoh et al, 1994a, b) was associated with poor prognosis in lung carcinoma as well as in colon carcinoma (Campo et al, 1994) . In contrast to our previous studies, the second aim of this study was to correlate both native *Dedicated to Professor Hans Fritz on the occasion of his 60th anniversary acidic cath B activity at pH 6.0 and a cath B fraction, which is stable and active at physiological pH of 7.5 in lung tumour tissue, to the histopathology and clinical status of the disease. Finally, the influence of both cath B fractions on the probability of survival of lung cancer patients was studied.
MATERIALS AND METHODS Chemicals
The substrate 7-[N-Benzyloxycarbonyl-L-arginyl-L-arginylamido]-4-methylcoumarin *2HCl H20 (Z-Arg-Arg-AMC) was purchased from Novabiochem (Laufelfingen, Switzerland). The inhibitor 1-[L-N-(trans-epoxysuccinyl)-leucyl]amino-4-guanidinobutan (E-64) was obtained from Sigma (Deisenhofen, Germany). The inhibitor propyl amide of epoxysuccinyl-L-Leu-L-Pro-OH (CA-074) was a gift from Taisho Pharmaceutical Company, Japan. The protein determination assay was purchased from Biorad (Munich, Germany). All other chemicals were of analytical grade and were obtained from commercial sources. The substrate Z-Arg-Arg-AMC and the inhibitors E-64 and CA-074 (Buttle et al, 1992) were stored as 10 mm stock solutions in dimethyl sulphoxide (DMSO) at 4°C. They were diluted to appropriate concentration with 0.1% (w/v) Brij in water before use.
Patients
Non-cancerous lung tissue (normal) and lung tumour tissue were obtained as paired samples from 91 patients with recognized lung tumours resected by surgery. The age of patients ranged from 15 to 81 years (mean 58.4 years). The normal tissue was taken from areas at least 6 cm apart from the tumour. Most of the patients were smokers. The cell type of lung cancer was classified according to the WHO protocol and based on the predominant cell type (World Health Organization, 1981) . The tumour disease stage (pTNM) was classified according to the international staging system (Hermanek and Sobin, 1987) .
Tissue homogenization
Tissue homogenization was performed as described earlier (Werle et al, 1995) . Briefly, tumour and lung tissue from the same lobe were frozen in liquid nitrogen immediately upon removal and kept at -80°C until homogenates were prepared. Lung tumour (0.1-6 g) and corresponding lung tissue (0.5-4 g) were thawed, washed with 0.9% sodium chloride solution and homogenized with 7 vol (w/v) of 50 mM sodium acetate buffer, pH 5.0, containing 100 mm sodium chloride, 4.0 mm sodium EDTA and 0.1% Triton X-100 (v/v) (homogenization buffer) in an Ultra-Turrax (Janke und Kunkel, Staufen, Germany, adapter 18 kg or 10 N, 4 x 60 s, 1/1 speed, 4°C).
In order to avoid rise of temperature, homogenization was interrupted after each 30 s. The resulting homogenate was left for a minimum of 60 min at 4°C. Then, debris was removed by centrifugation in a Sorvall Instrument RC5C, rotor SS-34, at 39 000 x g for 30 min. The supernatants were filtered through a 0.45-,um sterile filter from Millipore (Eschborn, Germany) and 100-1000 ,ul aliquots were made. The aliquots were kept frozen at -80°C.
Determination of protein concentration
Protein concentrations were determined according to Bradford (1976) . Bovine serum albumin was used as a standard.
Determination of cath B activity
Aliquots of supernatants were thawed, centrifuged for 10 min at 17 000 g in a Heraeus Biofuge 15 R (Heraeus, Osterode, Germany) and kept at 4°C. Dilutions of aliquots to appropriate protein concentration were made with the homogenization buffer, pH 5.0. A thawed aliquot was used only once for cath B activity determination.
Cath B activity measurements were done with the substrate Z-Arg-Arg-AMC according to Barrett and Kirschke (1981) pH optimum of cath B activity
To generate pH profiles for cath B activity, stock buffer solutions of different pH values were prepared. Buffers used were 100 mm sodium citrate (pH 3.5-4.0); 100 mm sodium acetate (pH 4.0-6.0); 100 mm sodium phosphate (pH 5.0-8.0) and 100 mm Tris (pH 8.5-9.5), all containing 1.35 mm sodium EDTA. Aliquots of the tissue homogenates with approximately 60 jig of protein were measured with Z-Arg-Arg-AMC in the range of pH 3.5 up to 9.5 as described above.
Stability of cath B at pH 7.5 To test the stability of cath B at pH 7.5, samples (diluted aliquots with approximately 60 jg of protein) were preincubated for 60 min in 100 mm phosphate buffer, pH 7.5, at 25°C. Residual cath B activity was measured at pH values in the range 5.0-8.0 in 100 mm sodium phosphate buffer, including 1.35 mm sodium EDTA. L-cysteine base was added to activate the enzyme (2.7 mm final concentration) and the actual pH of reaction mixtures was measured after the addition of tissue extract. Subsequently, cath B assays were performed as described above. In control experiments, 5 jM E-64 was added to the sample before the activation buffer. In addition, inhibitor CA-074, 5 jiM final concentration, was added to each sample to test the specificity of the reaction (Buttle et al, 1992) . Unspecific activities have been subtracted.
Statistical analysis
The results of cath B activity assays in the groups under study are given as 5%, 50% (median) and 95% percentiles. To compare data of tumour and lung tissue, we used the two-tailed Wilcoxon's rank test. The correlation between activities of native, acidic cath B and cath B at pH 7.5 was calculated by linear regression analysis and pH Figure 1 pH dependence of native cath B activity. Native cath B activities at indicated pH were measured with the specific substrate Z-Arg-Arg-AMC at 250C using the standard assay (Barrett and Kirschke, 1981) . Control of specificity of cath B activity was performed with E-64 (data not shown) and CA-074 (tumour tissue, 0; normal tissue, +) as described in Materials and methods. A and B show an average of cath B activity in six squamous cell carcinomas (A, *) and two adenocarcinomas (B, *). Both histological types were compared with their corresponding normal tissues (O). The data are presented as relative cath B activities, where the highest activity at the pH optimum was taken as 100% the significance of the Spearman rank correlation coefficient was evaluated by co-variance test. The calculation of survival probability was performed by the method developed by Kaplan and Meier (1958) . The significance of a relationship between survival of patients and the levels of the biochemical parameters was based on the log-rank test using various statistical packages (PCStatistik, Topsoft, Germany; SPSS, IL, USA; Statistica, StatSoft, Germany). The discrimination levels were calculated by the Critlevel program (Abel et al, 1984) .
RESULTS pH dependence of cath B activity in tissue homogenates
The pH dependence of the cath B activity in extracts from lung tumour tissue and normal lung is shown in Figure IA 30 20 10 4.5 5 5.5 6 6.5 7 7.5 8 8.5 pH Figure 2 Stability of cath B activity at pH 7.5. To test the stability of cath B at physiological pH of 7.5, aliquots were incubated for 60 min in 100 mm phosphate buffer, pH 7.5, at 250C. Cath B activity was measured at the indicated pH values with the specific substrate Z-Arg-Arg-AMC at 250C. Control of cath B specificity was performed using specific inhibitors E-64 (data not shown) and CA-074 (data not shown). Higher cath B fraction, active at pH 7.5, was found in 63 tumour homogenates. A and B show an average of two squamous cell carcinomas (0) and two adenocarcinomas (-), both compared with their normal tissues (U). Data are presented as relative cath B activities, where the highest activity (pH optimum) was taken as 100% of squamous cell carcinoma and in Figure lB for two cases of adenocarcinoma. In all cases under study, the maximum activity was observed between pH 6.0 and 6.5. This finding is in accordance with values reported for the purified enzyme (Barrett and Kirschke, 1981; Willenbrock and Brocklehurst, 1985; Koga et al, 1991) . However, curves obtained from the extracts show a threephasic profile with the major peak at pH 6.0-6.5 and with shoulders in the acidic (pH 4.5-5.5) and in the neutral to basic range (pH 7.5-8.0). Interestingly, the last is more pronounced in adenocarcinoma. The addition of inhibitors, E-64 or CA-074, completely inhibited the activity below pH 6.5, but there was still some activity above this point. This indicates that the activity measured below pH 6.5 was only caused by cath B, while above pH 6.5 small amounts of a non-cysteine protease activity were also measured. These unspecific activities have been subtracted before performing statistical analyses. There was no qualitative difference in the pH dependence of the cath B activity between tumour and normal tissue.
British Journal of Cancer (1997) 75(8) Stability of cath B activity at pH 7.5
We found considerable amounts of cath B activity after preincubation of the samples at pH 7.5 for 60 min at 25°C, indicating stability of cath B in tissue homogenates at physiological pH. This treatment led to a complete change of pH dependency of cath B activity. The results of two squamous cell carcinomas and two adenocarcinomas together with their normal counterparts are shown in Figure 2A and 2B respectively. Surprisingly, activity in the pH range of 5.0-5.5 remains at the absolute level (82-100%) as in the untreated control (i.e. acidic shoulder). In the pH range 5.5-7.4, the activity was markedly reduced in both types of tissue from 82-100% to 26-42%. At pH 7.5, there was still 20-34% residual cath B activity detectable. All activities were sensitive to E-64 and CA-074. No difference in the profile of pH optimum was observed between tumour and normal tissues. Also, there was no significant difference between squamous cell carcinoma and adenocarcinoma in this respect.
Cath B activity in matched pairs of tumour and normal lung tissue Cath B activity was measured in 91 matched pairs of tumour and normal lung tissue homogenates using two different conditions. Measurement was done at pH 6.0 following the standard protocol yielding native, acidic cath B activity and, after preincubation at pH 7.5 for 60 min, with a slightly modified procedure yielding a cath B fraction active at pH 7.5. The results are listed in Table 1 . In comparison with the normal counterpart, we found a 5.4-fold increase (P < 0.001) of native, acidic cath B and a 2.3-fold increase (P < 0.001) of the cath B fraction active at pH 7.5 in tumour tissues. In 89 out of the 91 tumour homogenates, there was a higher native, acidic cath B activity than in the corresponding lung homogenates. In 63 out of the 91 specimens, the cath B fraction at pH 7.5 was increased. Nevertheless, native, acidic cath B activity was always higher than the cath B fraction at pH 7.5. The increase in native, acidic cath B activity in tumour tissue was 6.1-fold (P < 0.001) and in normal tissue 2.6-fold (P < 0.001) compared with the cath B fraction at pH 7.5. Therefore, the increase in tumour-associated cath B activity is mainly related to acidic cath B, active at pH 6.0, rather than to cath B active at pH 7.5.
Correlation of cath B activity with clinical and histopathological parameters
To establish a potential clinical relevance of the native, acidic as well as the cath B fraction at pH 7.5, we compared the results of activity measurement with classical clinical factors of prognostic significance (Table 1) . With regard to histological cell type, we only found minor differences in the cath B activities. However, squamous cell carcinomas showed the highest tumour-lung ratio in both cath B fractions. Poorly differentiated carcinomas had nonsignificantly higher cath B activities than moderately or welldifferentiated tumours. No correlation was found between cath B activities and TNM stages (data not shown). Furthermore, we found only a non-significant difference of both activities between male and female patients. To evaluate the influence of patients' age on cath B activities, we subdivided the study population into four classes owing to the extremely wide range from 15 to 81 years. Class I (< 35 years), class 11 (35-55 years), class III (56-65 years) and class IV (> 65 years) consisted of 5, 24, 39 and 23 patients respectively. There was no significant correlation of both cath B activities with age. Also, no significant association with age could be demonstrated when considering only the 62 male patients. The values are further subdivided according to histology and cell differentiation. aMedian value of the ratio of specific cath B activities in tumour tissue (Tu) vs specific cath B activities in normal tissue (Lu). bAddition of subgroups is not equal to 91, because Gx categories could not be assessed. NS, not significant. Association of cath B activity with survival probability
To compare both native, acidic cath B and cath B active at pH 7.5 with survival probability of patients, we performed univariate Kaplan-Meier analyses (Table 2 ). In contrast to native, acidic cath B, we found a prognostic significant influence of the cath B fraction at pH 7.5 on 2 years' survival only in patients with squamous cell carcinoma (P = 0.04). There was no significant association of both cath B activities and the survival probability of patients with adenocarcinoma. Remarkably, 90% of the values of cath B active at pH 7.5 in normal lung homogenates were below the value of 292
(gEU mg-' protein), which we used as the discrimination level for survival analyses in tumour samples. Figure 3A and B shows the Kaplan-Meier-plots concerning these data.
DISCUSSION
Cathepsin B is characterized as a cysteine protease, optimally active against synthetic substrates at pH 6.0-6.5. Above pH 7.0, the purified enzyme becomes rapidly inactivated in vitro (Turk et al, 1994; Kirschke et al, 1995) . Considering its possible role in extralysosomal and extracellular proteolysis in tumour development and progression, it was speculated that some molecular forms of cath B are stable and active at physiological pH around 7.5 (Mort et al, 1980; Pagano et al, 1989; Sheahan et al, 1989; Moin et al, 1992) . Therefore, we analysed cath B activities in tumour and normal tissue extracts from human lungs obtained at surgery, at different pH values. As we found no qualitative differences in the pH activity profiles between tumour and normal tissues, we conclude that a tumour-specific cath B molecular form(s) with a pH optimum at neutral to alkaline pH is unlikely to exist. However, besides the major peak at pH 6.0, there were shoulders at pH 4.5-5.5 and at pH 7.0-7.5, indicating multiple isoforms of cath B. Incubating homogenates of tumour tissue and normal lung at pH 7.5 for 60 min, a marked change in the pH profile of cath B was observed (Figure 2A and B) : the activity at pH about 5.0 remained constant, while the activity at pH 6.0-6.5 decreased considerably, and there was still activity at pH 7.5. These differential stability of cath B activities at various pH may be explained either by the existence of natural mutants of cath B being more or less stable at physiological pH and/or by the binding of cath B to the endogenous protease inhibitors. Polgar and Csoma (1987) and Koga et al (1991) reported on a broad substrate specificity of cath B being dependent on pH. It was found that dipeptidyl-carboxypeptidase activity has its optimum at intralysosomal pH of 4.7-4.8, while the optimum for endopeptidase activity was at pH 6.0. Larger protein substrates were also hydrolyzed by normal and tumour cath B at pH 7.5 (Lah et al, 1989; Buck et al, 1992) . It was speculated that the endo-vs exopeptidase activity of cath B was regulated by a pH-dependent conformational change in the active site of cath B. Different isoforms (charged forms) of cath B may therefore not be the only ones responsible for the change in substrate specificity. This is further supported by the findings of Deval et al (1990) who demonstrated two different purified isoforms of cath B with very similar pH optimum profiles, and that one single isolated isoform of cath B may display a pH profile with 'shoulders' in the acidic and in the slightly alkaline range. Hasnain et al (1992) found that British Journal of Cancer (1997) 75(8) Werle et al, 1995; Ledakis et al, 1996) (Sheahan et al, 1989) , who found that the tumour cath B activity at pH 8.0 was more stable than in adjacent colon tissue.
In our study, neither the acidic cath B activity nor the minor fraction of alkaline-stable cath B activity at pH 7.5 correlated with clinical and histopathological parameters associated with tumour progression. The association of native, acidic cath B activity in tumours was found initially, as we demonstrated that the fraction of cath B active at pH 6.0 was close to being prognostic for the survival of patients after 6 months of follow-up (1994a, b) who clearly demonstrated that the components of the plasminogen activator system (uPa, uPA receptor and PAI-1) are of prognostic significance in lung carcinoma. The median levels of uPA receptor and the combination of uPA receptor and PAI-I were correlated with prognosis in squamous cell carcinomas, while only PAI-I was significant for the prognosis of patients with adenocarcinomas. These factors were independent of other prognostic parameters. On the contrary, in patients with large-cell carcinoma, none of the factors of the plasminogen activator-plasmin system correlated with survival probability.
As concluded from this and other studies, the proteolytic system comprising the cysteine proteases, in particular cath B, seems to be of importance for the progression of certain histological types of lung cancer. In order possibly to interfere with these proteolytic events and the progression of malignant tumours, the role of this enzyme has to be understood in more detail, not only in tumour but also in the surrounding tissues.
